sellas life sciences stock

Significant News Only No significant news for SLS in the past two years. According to the issued ratings of 2 analysts in the last year the consensus rating for SELLAS Life Sciences Group stock is Buy based on the current 2 buy ratings for SLS.

Sellas Life Sciences Group Nasdaqcm Sls Share Price News Analysis Simply Wall St

News SELLAS Life Sciences Group Inc.

. Rooms Rankings Earnings Newsletters Shop. According to 8 analysts the average rating for SLS stock is Buy The 12-month stock price forecast is 102 which is an increase of 23887 from the latest price. Ad In this free report we detail why this value stock is our experts top pick.

Contact United States Of America. SLS Stock Price News Info The Motley Fool SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group Inc.

It also could bring an upfront payment of 75 million sometime this quarter. Our analyst reveals value stock is set to grow 30 in 2022. Is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad.

Targeting Maximum Gains from the 30 Trillion Metaverse. Stock analysis for SELLAS Life Sciences Group Inc RXK3Frankfurt including stock price stock chart company news key statistics fundamentals and company profile. Heres where we think you should invest.

Check if SLSL Stock has a Buy or Sell Evaluation. Sellas Life Sciences stock forecast. Now is the time to move.

Ad Just-released report reveals stock recommendations to profit from emerging metaverse tech. Ad Extra money in your bank account. SELLAS Life Sciences Group Inc.

About SELLAS Life Sciences Group. SELLAS Life Sciences Inks License Deal With GenFleet Therapeutics For CDK9 Inhibitor. SLS Nasdaq Capital Market Nasdaq SLS 245 -007 -28 Price as of.

Its product pipeline includes galinpepimut-S and ct. Real-time trade and investing ideas on SELLAS Life Sciences Group Inc SLS from the largest community of traders and investors. According to the estimates compiled by CNN only two analysts are covering Sellas Life Sciences stock and its median price target is 8.

According to a company press release this could net 202 million in license fees for SELLAS. Ad These 5 companies are set for historic price action. See SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc. A rare market phenomena could change everything and theres no telling when it will occur. Get Sellas Life Sciences Group Inc SLSNASDAQ real-time stock quotes news price and financial information from CNBC.

SELLAS Life Sciences Group Inc. Find real-time SLS - Sellas Life Sciences Group Inc stock quotes company profile news and forecasts from CNN Business. SELLAS Life Sciences Group Inc.

7 Times Square Suite 2503 New York NY 10036 646-200-5278. Stock Down RTTNews Mar 31 2022 See All News About SELLAS Life Sciences Group Inc. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

The company traded as low as 296 and last traded at. SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer. A high-level overview of SELLAS Life Sciences Group Inc.

The market shed around 15 no doubt weighing on the stock price. SLSL Stock Price XLON Forecast Predictions Stock Analysis and SELLAS Life Sciences Group Inc News. The stock traded as low as 296 and last traded at 298.

Engages in the development and commercialization of immunotherapeutic for cancer indications. SLS Stock Price Movement As of August 19 2022 the SLS stock price is 325. Stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.

NASDAQSLS Get Rating shares dropped 17 during mid-day trading on Friday. Over the previous five trading days SLS stock is up 48 compared with being down -6041. NASDAQSLS Get Rating traded down 17 during mid-day trading on Friday.

Key Stock Data PE Ratio TTM NA EPS TTM -233 Market Cap 6366 M. SELLAS Life Sciences Group shareholders are down 67 for the year falling short of the market return. Diversify your portfolio with guidance from investment professionals.

Sls Institutional Ownership And Shareholders Sellas Life Sciences Group Inc Nasdaq Stock